Possible causal factors of structural chromosome aberrations in intracytoplasmic sperm injection of the mouse

Risk of chromosomal aberration in spermatozoa during intracytoplasmic sperm injection

Intracytoplasmic sperm injection (ICSI) has become critical for the treatment of severe male infertility. The principal feature of ICSI is the direct injection of spermatozoon into an oocyte, which facilitates the production of fertilized embryos regardless of semen characteristics, such as sperm concentration and motility. However, the chromosomal integrity of ICSI zygotes is degraded compared to that of zygotes obtained via in vitro fertilization. This chromosomal damage may occur due to the injection of non-capacitated, acrosome-intact spermatozoa, which never enter the oocytes under natural fertilization. Furthermore, it is possible that the in vitro incubation and pre-treatment of spermatozoa during ICSI results in DNA damage. Chromosomal aberrations in embryos induce early pregnancy losses. However, these issues may be overcome by embryo production using gametes with guaranteed chromosomal integrity. Because conventional chromosome analysis requires fixing cells to obtain the chromosome spreads, embryos cannot be produced using the nucleus that has been analyzed. On the other hand, genome cloning using androgenic or gynogenic embryos provides an additional nucleus for chromosome analysis following embryo production. Thus, this review aims to highlight the hazardous nature of chromosomal aberrations in sperm during ICSI and to introduce a method for the prezygotic examination for chromosomal aberrations.

Chromosome analysis of mouse zygotes produced by intracytoplasmic injection of spermatozoa exposed to acrosome reaction inducing agents methyl-beta-cyclodextrin and calcium ionophore A23187

PURPOSE

This study was performed to investigate whether removal of cholesterol from the plasma membrane and collapse of the acrosome can prevent structural chromosome aberrations of paternal origin in mouse zygotes produced by intracytoplasmic sperm injection (ICSI).

METHODS

Mouse spermatozoa were treated with methyl-beta-cyclodextrin (M beta CD) to remove cholesterol from the plasma membrane and with calcium ionophore A23187 to collapse the acrosome. Chromosomes of zygotes derived from M beta CD- and ionophore-treated spermatozoa were analyzed at the first mitotic metaphase.

RESULTS

Both chemical agents effectively induced the acrosome reaction. Incidence of structural chromosome aberrations in ICSI zygotes derived from M beta CD-treated spermatozoa was similar to that in zygotes produced by in vitro fertilization (IVF) with the same spermatozoa, but significantly lower compared to ICSI zygotes derived from acrosome-intact spermatozoa. Chromosome aberration rates in ICSI zygotes derived from ionophore-treated spermatozoa were evidently high compared to IVF zygotes.

CONCLUSIONS

Induction of the acrosome reaction through cholesterol efflux by M beta CD can prevent chromosome aberrations of paternal origin, while use of ionophore to induce the acrosome reaction exerts detrimental effect on paternal chromosomes in ICSI zygotes.